121 results
Page 4 of 7
8-K
EX-99.2
hmrgd
9 Jun 22
Immunome Announces Initiation of Phase 1b Study of IMM-BCP-01 for the Treatment of COVID-19
8:32am
DEFA14A
hc46rdcxw47lgpqj
29 Apr 22
Additional proxy soliciting materials
4:40pm
S-3
EX-1.2
lx006cz
1 Oct 21
Shelf registration
4:42pm
S-3
EX-4.4
e7eu3u3 359x
1 Oct 21
Shelf registration
4:42pm
S-3
ve97 wyi8ls07
1 Oct 21
Shelf registration
4:42pm
S-3
EX-4.5
yqsxz3 t9hgp
1 Oct 21
Shelf registration
4:42pm
8-K
EX-10.1
gf1nr48 bobbmx
5 Aug 21
Departure of Directors or Certain Officers
4:36pm
D
342nw52xslliriuqq
11 May 21
$27M in equity / options / securities to be acquired, sold $27M, 47 investors
5:20pm
8-K
EX-10.1
1v9og3o
26 Apr 21
Immunome Announces $27 Million Private Placement
6:05am